Protection conferred by the RTS,S malaria vaccine depends greatly on the amount and subclass of antibodies generated upon vaccination and on previous exposure levels to the parasite, according to a study led by ISGlobal. ...
Oct 31, 2018
0
2
A recent study conducted in the University of Jyväskylä suggests that resistance training improves exercise motivation and contributes to making exercise planning among older adults. Exercise motivation and exercise self-efficacy ...
Aug 15, 2018
0
8
The current whooping cough vaccine was universally adopted in the US in 1996 to replace the original vaccine based on killed Bordetella pertussis because of a stronger safety profile. The new formulation was found to be effective ...
Jul 9, 2018
0
9
A Rice University study predicts that this fall's flu vaccine—a new H3N2 formulation for the first time since 2015—will likely have the same reduced efficacy against the dominant circulating strain of influenza A as the ...
Apr 19, 2018
0
139
Results from a Phase 3 efficacy study in India of the Serum Institute of India Pvt. Ltd.'s rotavirus vaccine BRV-PV (known as ROTASIIL) were published in the journal Vaccine. The study showed the vaccine to be safe, well ...
Sep 26, 2017
0
1
(HealthDay)—Percutaneous bleomycin injections are effective and tolerable for the treatment of vascular malformations, according to a study published online Sept. 4 in the International Journal of Dermatology.
Sep 23, 2017
0
0
Concurrent administration of the T-cell stimulating anti-OX40 antibody and the immune checkpoint inhibitor anti-PD1 antibody attenuated the effect of anti-OX40 and resulted in poor treatment outcomes in mice.
Aug 28, 2017
0
0
Pregnant women who receive the pertussis (whooping cough) vaccine have babies who are less likely to suffer from this highly contagious respiratory tract infection during their first year of life, according to a recent study.
May 9, 2017
0
1
A widely shared story that U.S. health officials are recommending a delay in breast-feeding to improve vaccine effectiveness is false.
Apr 10, 2017
0
49
Two investigational agents, Aurora A kinase inhibitor (alisertib) and HSV1716, a virus derived from HSV-1 and attenuated by the deletion of RL1, have shown some antitumor efficacy in early clinical trials as monotherapies. ...
Feb 9, 2017
0
2
